Filters

LRFN2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LRFN2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) size: 1.0 µg DNA 600

Price 600
Size 1.0 µg DNA
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetLRFN2 Lentiviral Vector (EF1a) (pLenti-GIII-EF1a)
Short nameLRFN2 Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (EF1a) (pLenti-GIII-EF1a), LRFN2 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 21226
Gene LRFN2
Long gene name leucine rich repeat and fibronectin type III domain containing 2
Synonyms gene KIAA1246 SALM1
Synonyms gene name KIAA1246
Synonyms FIGLER2
Synonyms name fibronectin type III, immunoglobulin and leucine rich repeat domains 2
Locus 6p21, 1 , 2-p21
Discovery year 2003-11-21
GenBank acession AB033072
Entrez gene record 57497
Pubmed identfication 16495444 16828986
RefSeq identity XM_166372
Classification I-set domain containing Fibronectin type III domain containing
Havana BLAST/BLAT OTTHUMG00000014662

Subscribe to our Newsletter